These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1323901)

  • 1. Soluble proteins incorporate into ISCOMs after covalent attachment of fatty acid.
    Reid G
    Vaccine; 1992; 10(9):597-602. PubMed ID: 1323901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel ISCOMs from Quillaja brasiliensis saponins induce mucosal and systemic antibody production, T-cell responses and improved antigen uptake.
    Cibulski SP; Mourglia-Ettlin G; Teixeira TF; Quirici L; Roehe PM; Ferreira F; Silveira F
    Vaccine; 2016 Feb; 34(9):1162-71. PubMed ID: 26826546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incorporation of soluble antigens into ISCOMs: HIV gp120 ISCOMs induce virus neutralizing antibodies.
    Browning M; Reid G; Osborne R; Jarrett O
    Vaccine; 1992; 10(9):585-90. PubMed ID: 1380196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation of immune stimulating complexes (ISCOMs) as adjuvants.
    Mowat AM; Reid G
    Curr Protoc Immunol; 2001 May; Chapter 2():Unit 2.11. PubMed ID: 18432764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and quantification of Quillaja saponaria Molina saponins and lipids in iscom-matrix and iscoms.
    Behboudi S; Morein B; Rönnberg B
    Vaccine; 1995 Dec; 13(17):1690-6. PubMed ID: 8719521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the structure of immune-stimulating saponin-lipid complexes (iscoms).
    Kersten GF; Spiekstra A; Beuvery EC; Crommelin DJ
    Biochim Biophys Acta; 1991 Feb; 1062(2):165-71. PubMed ID: 2004105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iscoms containing purified Quillaja saponins upregulate both Th1-like and Th2-like immune responses.
    Sjölander A; van't Land B; Lövgren Bengtsson K
    Cell Immunol; 1997 Apr; 177(1):69-76. PubMed ID: 9140097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of iscoms and their adjuvant moiety (matrix) on the initial proliferation and IL-2 responses: comparison of spleen cells from mice inoculated with iscoms and/or matrix.
    Fossum C; Bergström M; Lövgren K; Watson DL; Morein B
    Cell Immunol; 1990 Sep; 129(2):414-25. PubMed ID: 2383899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current status and potential application of ISCOMs in veterinary medicine.
    Morein B; Hu KF; Abusugra I
    Adv Drug Deliv Rev; 2004 Jun; 56(10):1367-82. PubMed ID: 15191787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Internalization of iscom-borne antigens and presentation under MHC class I or class II restriction.
    Villacres MC; Behboudi S; Nikkila T; Lovgren-Bengtsson K; Morein B
    Cell Immunol; 1998 Apr; 185(1):30-8. PubMed ID: 9636680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral vaccination with immune stimulating complexes.
    Mowat AM; Smith RE; Donachie AM; Furrie E; Grdic D; Lycke N
    Immunol Lett; 1999 Jan; 65(1-2):133-40. PubMed ID: 10065639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune-stimulating complexes containing Quil A and protein antigen prime class I MHC-restricted T lymphocytes in vivo and are immunogenic by the oral route.
    Mowat AM; Donachie AM; Reid G; Jarrett O
    Immunology; 1991 Mar; 72(3):317-22. PubMed ID: 2026440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iscom, a delivery system for parenteral and mucosal vaccination.
    Morein B; Villacrés-Eriksson M; Lövgren-Bengtsson K
    Dev Biol Stand; 1998; 92():33-9. PubMed ID: 9554257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hydration of lipid films with an aqueous solution of Quil A: a simple method for the preparation of immune-stimulating complexes.
    Copland MJ; Rades T; Davies NM
    Int J Pharm; 2000 Mar; 196(2):135-9. PubMed ID: 10699704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liposomes and ISCOMs.
    Kersten GF; Crommelin DJ
    Vaccine; 2003 Feb; 21(9-10):915-20. PubMed ID: 12547602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant activity of non-toxic Quillaja saponaria Molina components for use in ISCOM matrix.
    Rönnberg B; Fekadu M; Morein B
    Vaccine; 1995 Oct; 13(14):1375-82. PubMed ID: 8585296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of antibody and T-cell responses by immunization with ISCOMS containing the 38-kilodalton protein of Mycobacterium tuberculosis.
    da Fonseca DP; Frerichs J; Singh M; Snippe H; Verheul AF
    Vaccine; 2000 Aug; 19(1):122-31. PubMed ID: 10924794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune-stimulating complexes as adjuvants for inducing local and systemic immunity after oral immunization with protein antigens.
    Mowat AM; Maloy KJ; Donachie AM
    Immunology; 1993 Dec; 80(4):527-34. PubMed ID: 7508416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunostimulatory complexes containing Eimeria tenella antigens and low toxicity plant saponins induce antibody response and provide protection from challenge in broiler chickens.
    Berezin VE; Bogoyavlenskyi AP; Khudiakova SS; Alexuk PG; Omirtaeva ES; Zaitceva IA; Tustikbaeva GB; Barfield RC; Fetterer RH
    Vet Parasitol; 2010 Jan; 167(1):28-35. PubMed ID: 19879050
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Saponins from Quillaja saponaria Molina: isolation, characterization and ability to form immuno stimulatory complexes (ISCOMs).
    Pham HL; Ross BP; McGeary RP; Shaw PN; Hewavitharana AK; Davies NM
    Curr Drug Deliv; 2006 Oct; 3(4):389-97. PubMed ID: 17076641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.